US Broker Ratings

Indivior PLC (INDV) Stock Analysis: Evaluating Growth Potential with a 5.14% Upside

Indivior PLC (INDV) stands as a noteworthy player in the healthcare sector, focusing on the crucial field of substance use disorder treatment. With a market capitalization of $1.76 billion, this..

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator with a Strong Buy Consensus and Strategic Growth Potential

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, particularly within the medical devices industry, is currently drawing considerable attention from investors. With a market capitalization of $1.45..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Innovator with Promising Buy Ratings

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its focus on cutting-edge therapeutics for neuromuscular diseases. With a market capitalization of $1.15 billion, the company..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Analyzing a 40% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing investment opportunity in the healthcare sector, particularly for those eyeing the medical care facilities industry. With a market capitalization of $1.15..

Novavax, Inc. (NVAX) Growth Potential: Analyzing the Surging Revenue and Future Prospects

As investors seek opportunities in the ever-evolving biotechnology sector, Novavax, Inc. (NASDAQ: NVAX) emerges as a captivating candidate for those with an appetite for high-growth potential. Headquartered in Gaithersburg, Maryland,..

Certara, Inc. (CERT) Stock Analysis: Exploring a 50% Upside Potential in the Healthcare Tech Sector

Certara, Inc. (NASDAQ: CERT), a key player in the healthcare technology landscape, is attracting significant attention from investors, thanks to its potential upside of over 50%. With a market capitalization..

Structure Therapeutics Inc. (GPCR): A Biotech with a Remarkable 245% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a dynamic player in the biotechnology sector, is capturing investor attention with its ambitious pipeline and significant potential upside. The company, valued at $1.27 billion,..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Assessing the 11.43% Potential Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD) presents a compelling investment opportunity in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Brentwood, Tennessee, Brookdale stands as a..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A Biotech Gem with a 192.64% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is capturing investor attention with its promising pipeline in the biotechnology sector and an impressive potential upside of 192.64%. As a clinical-stage biotech company, Vera..

Addus HomeCare Corporation (ADUS): Investor Outlook Reveals 20.75% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) stands out in the healthcare sector with a compelling case for investors seeking opportunities in the medical care facilities industry. With a market capitalization of..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 10.71% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector, offers a diverse range of sample exploration and management solutions tailored for the life sciences market. With its headquarters..

Metsera, Inc. (MTSR) Stock Analysis: A Biotech Gem with an 89.66% Upside Potential

For investors keen on tapping into the dynamic world of biotechnology, Metsera, Inc. (NASDAQ: MTSR) presents a compelling opportunity. A clinical-stage company focused on addressing obesity and related disorders, Metsera..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Unveiling a Potential 166.88% Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is garnering significant attention in the biotechnology sector with its promising potential upside of 166.88%. As a clinical-stage biopharmaceutical company, Mineralys is dedicated to developing..

Arcutis Biotherapeutics, Inc. (ARQT): Investor Outlook with a 46.83% Upside Potential

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) has captured investors’ attention within the healthcare sector, particularly in the biotechnology industry, as it continues to push boundaries in dermatological treatments. With a market..

Evolent Health, Inc (EVH) Stock Analysis: A 43.59% Potential Upside That Investors Shouldn’t Overlook

Evolent Health, Inc. (EVH), a prominent player in the healthcare sector specializing in health information services, is showing potential that could interest savvy investors looking for growth opportunities. With a..

MiMedx Group, Inc (MDXG) Stock Analysis: A Promising Upside of Over 102% in the Biotech Arena

MiMedx Group, Inc (NASDAQ: MDXG) stands out in the biotechnology sector, drawing investor attention with its innovative approach to wound care and surgical products. With a current market cap of..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A 163% Potential Upside Awaits Investors

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering biotechnology company based in Cambridge, Massachusetts, is making waves in the healthcare sector with its cutting-edge precision genetic medicines. As investors scour the..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Assessing Growth Potential with a 4.9% Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a pivotal player within the healthcare sector, providing essential management and operational services to medical care facilities across the United States. With..

NeoGenomics, Inc. (NEO) Stock Analysis: Evaluating a Potential 60% Upside in the Healthcare Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, has been making waves with its focus on cancer diagnostics and research. With a current market capitalization of $902.15..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 27.71% Potential Upside Ignites Investor Interest

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, is making waves in the healthcare sector with its innovative therapies targeting autoimmune diseases. Investors are taking a closer look at..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds